6 research outputs found

    NARRATIVAS SOBRE A EDUCAÇÃO INCLUSIVA: DESAFIOS E TENSÕES NA PRÁTICA PEDAGÓGICA

    Get PDF
    A formação do professor é um desafio na proposta de escola inclusiva, sendo uma atividade de suma importância, posto que a educação é para todos, mas a maioria dos professores não estão preparados para atender estudantes público alvo da educação especial. Um dos desafios fundamentais que emergem da proposta de escola inclusiva é a formação do professor, que para Fávero (2009) é, justamente, o de repensar e ressignificar a própria concepção de educador. Isto porque, o processo educativo consiste na criação e no desenvolvimento de “contextos” educativos que possibilitem a interação crítica e criativa entre sujeitos singulares, e não simplesmente na transmissão e na assimilação disciplinar de conceitos e comportamentos estereotipados. O Núcleo de Tecnologia Educacional de Aquidauana, órgão ligado a Secretaria de Estado de Educação de Mato Grosso do Sul, propõe a formação continuada “o uso das tecnologias assistivas na prática pedagógica”, enfatizando a ação e a prática como processos de seleção e construção de conhecimentos por meio da produção simultânea, sequência didática interdisciplinar que priorizaram reflexões e debates sobre a inclusão/exclusão. É importante ressaltar que o professor busque conhecimento para que assim, possa distinguir os problemas para apresentar melhor alternativa de assimilação. Neste viés a formação continuada para inserção das tecnologias assistivas no meio acadêmico é imprescindível para a dinamização do processo de ensino e aprendizagem

    NARRATIVAS SOBRE A EDUCAÇÃO INCLUSIVA: DESAFIOS E TENSÕES NA PRÁTICA PEDAGÓGICA

    Get PDF
    A formação do professor é um desafio na proposta de escola inclusiva, sendo uma atividade de suma importância, posto que a educação é para todos, mas a maioria dos professores não estão preparados para atender estudantes público alvo da educação especial. Um dos desafios fundamentais que emergem da proposta de escola inclusiva é a formação do professor, que para Fávero (2009) é, justamente, o de repensar e ressignificar a própria concepção de educador. Isto porque, o processo educativo consiste na criação e no desenvolvimento de “contextos” educativos que possibilitem a interação crítica e criativa entre sujeitos singulares, e não simplesmente na transmissão e na assimilação disciplinar de conceitos e comportamentos estereotipados. O Núcleo de Tecnologia Educacional de Aquidauana, órgão ligado a Secretaria de Estado de Educação de Mato Grosso do Sul, propõe a formação continuada “o uso das tecnologias assistivas na prática pedagógica”, enfatizando a ação e a prática como processos de seleção e construção de conhecimentos por meio da produção simultânea, sequência didática interdisciplinar que priorizaram reflexões e debates sobre a inclusão/exclusão. É importante ressaltar que o professor busque conhecimento para que assim, possa distinguir os problemas para apresentar melhor alternativa de assimilação. Neste viés a formação continuada para inserção das tecnologias assistivas no meio acadêmico é imprescindível para a dinamização do processo de ensino e aprendizagem

    Spatiotemporal Characteristics of the Largest HIV-1 CRF02_AG Outbreak in Spain: Evidence for Onward Transmissions

    Get PDF
    Background and Aim: The circulating recombinant form 02_AG (CRF02_AG) is the predominant clade among the human immunodeficiency virus type-1 (HIV-1) non-Bs with a prevalence of 5.97% (95% Confidence Interval-CI: 5.41–6.57%) across Spain. Our aim was to estimate the levels of regional clustering for CRF02_AG and the spatiotemporal characteristics of the largest CRF02_AG subepidemic in Spain.Methods: We studied 396 CRF02_AG sequences obtained from HIV-1 diagnosed patients during 2000–2014 from 10 autonomous communities of Spain. Phylogenetic analysis was performed on the 391 CRF02_AG sequences along with all globally sampled CRF02_AG sequences (N = 3,302) as references. Phylodynamic and phylogeographic analysis was performed to the largest CRF02_AG monophyletic cluster by a Bayesian method in BEAST v1.8.0 and by reconstructing ancestral states using the criterion of parsimony in Mesquite v3.4, respectively.Results: The HIV-1 CRF02_AG prevalence differed across Spanish autonomous communities we sampled from (p < 0.001). Phylogenetic analysis revealed that 52.7% of the CRF02_AG sequences formed 56 monophyletic clusters, with a range of 2–79 sequences. The CRF02_AG regional dispersal differed across Spain (p = 0.003), as suggested by monophyletic clustering. For the largest monophyletic cluster (subepidemic) (N = 79), 49.4% of the clustered sequences originated from Madrid, while most sequences (51.9%) had been obtained from men having sex with men (MSM). Molecular clock analysis suggested that the origin (tMRCA) of the CRF02_AG subepidemic was in 2002 (median estimate; 95% Highest Posterior Density-HPD interval: 1999–2004). Additionally, we found significant clustering within the CRF02_AG subepidemic according to the ethnic origin.Conclusion: CRF02_AG has been introduced as a result of multiple introductions in Spain, following regional dispersal in several cases. We showed that CRF02_AG transmissions were mostly due to regional dispersal in Spain. The hot-spot for the largest CRF02_AG regional subepidemic in Spain was in Madrid associated with MSM transmission risk group. The existence of subepidemics suggest that several spillovers occurred from Madrid to other areas. CRF02_AG sequences from Hispanics were clustered in a separate subclade suggesting no linkage between the local and Hispanic subepidemics

    COVID-19 in hospitalized HIV-positive and HIV-negative patients : A matched study

    Get PDF
    CatedresObjectives: We compared the characteristics and clinical outcomes of hospitalized individuals with COVID-19 with [people with HIV (PWH)] and without (non-PWH) HIV co-infection in Spain during the first wave of the pandemic. Methods: This was a retrospective matched cohort study. People with HIV were identified by reviewing clinical records and laboratory registries of 10 922 patients in active-follow-up within the Spanish HIV Research Network (CoRIS) up to 30 June 2020. Each hospitalized PWH was matched with five non-PWH of the same age and sex randomly selected from COVID-19@Spain, a multicentre cohort of 4035 patients hospitalized with confirmed COVID-19. The main outcome was all-cause in-hospital mortality. Results: Forty-five PWH with PCR-confirmed COVID-19 were identified in CoRIS, 21 of whom were hospitalized. A total of 105 age/sex-matched controls were selected from the COVID-19@Spain cohort. The median age in both groups was 53 (Q1-Q3, 46-56) years, and 90.5% were men. In PWH, 19.1% were injecting drug users, 95.2% were on antiretroviral therapy, 94.4% had HIV-RNA < 50 copies/mL, and the median (Q1-Q3) CD4 count was 595 (349-798) cells/μL. No statistically significant differences were found between PWH and non-PWH in number of comorbidities, presenting signs and symptoms, laboratory parameters, radiology findings and severity scores on admission. Corticosteroids were administered to 33.3% and 27.4% of PWH and non-PWH, respectively (P = 0.580). Deaths during admission were documented in two (9.5%) PWH and 12 (11.4%) non-PWH (P = 0.800). Conclusions: Our findings suggest that well-controlled HIV infection does not modify the clinical presentation or worsen clinical outcomes of COVID-19 hospitalization

    How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

    Get PDF
    CatedresBackground: To estimate the prevalence and severity of menopausal symptoms and anxiety/depression and to assess the differences according to menopausal status among women living with HIV aged 45-60 years from the cohort of Spanish HIV/AIDS Research Network (CoRIS). Methods: Women were interviewed by phone between September 2017 and December 2018 to determine whether they had experienced menopausal symptoms and anxiety/depression. The Menopause Rating Scale was used to evaluate the prevalence and severity of symptoms related to menopause in three subscales: somatic, psychologic and urogenital; and the 4-item Patient Health Questionnaire was used for anxiety/depression. Logistic regression models were used to estimate odds ratios (ORs) of association between menopausal status, and other potential risk factors, the presence and severity of somatic, psychological and urogenital symptoms and of anxiety/depression. Results: Of 251 women included, 137 (54.6%) were post-, 70 (27.9%) peri- and 44 (17.5%) pre-menopausal, respectively. Median age of onset menopause was 48 years (IQR 45-50). The proportions of pre-, peri- and post-menopausal women who had experienced any menopausal symptoms were 45.5%, 60.0% and 66.4%, respectively. Both peri- and post-menopause were associated with a higher likelihood of having somatic symptoms (aOR 3.01; 95% CI 1.38-6.55 and 2.63; 1.44-4.81, respectively), while post-menopause increased the likelihood of having psychological (2.16; 1.13-4.14) and urogenital symptoms (2.54; 1.42-4.85). By other hand, post-menopausal women had a statistically significant five-fold increase in the likelihood of presenting severe urogenital symptoms than pre-menopausal women (4.90; 1.74-13.84). No significant differences by menopausal status were found for anxiety/depression. Joint/muscle problems, exhaustion and sleeping disorders were the most commonly reported symptoms among all women. Differences in the prevalences of vaginal dryness (p = 0.002), joint/muscle complaints (p = 0.032), and sweating/flush (p = 0.032) were found among the three groups. Conclusions: Women living with HIV experienced a wide variety of menopausal symptoms, some of them initiated before women had any menstrual irregularity. We found a higher likelihood of somatic symptoms in peri- and post-menopausal women, while a higher likelihood of psychological and urogenital symptoms was found in post-menopausal women. Most somatic symptoms were of low or moderate severity, probably due to the good clinical and immunological situation of these women

    QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial

    No full text
    corecore